Inotuzumab ozogamicin as chemotherapy-sparing salvage in a 67-year-old man with primary refractory B-cell acute lymphoblastic leukemia with high-risk genomic features

Older adults with acute lymphoblastic leukemia (ALL) continue to have a poor prognosis, in part due to greater chemotherapy-related toxicities. We herein report a 67-year-old man with Philadelphia chromosome (Ph)-negative B-cell ALL, who exhibited refractoriness to 3 different regimens of induction...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiaochuan, Sen, Filiz, Geyer, Mark B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904788/
https://www.ncbi.nlm.nih.gov/pubmed/31867204
http://dx.doi.org/10.1016/j.lrr.2019.100186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904788/
https://www.ncbi.nlm.nih.gov/pubmed/31867204
http://dx.doi.org/10.1016/j.lrr.2019.100186

Ejemplares similares